cromolyn sodium has been researched along with Pancreatic Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, CE; Kim, JS; Lim, SK | 1 |
Arumugam, T; Bornmann, WG; Logsdon, CD; Maxwell, DS; Pal, A; Peng, Z; Ramachandran, V; Sun, D | 1 |
Arumugam, T; Logsdon, CD; Ramachandran, V | 1 |
Theoharides, TC | 1 |
4 other study(ies) available for cromolyn sodium and Pancreatic Neoplasms
Article | Year |
---|---|
In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cromolyn Sodium; Female; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Phosphatidylcholines; Polyethylene Glycols; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium-Binding Proteins; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cromolyn Sodium; Drug Design; Drug Evaluation, Preclinical; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; NF-kappa B; Pancreatic Neoplasms; Protein Binding; Receptor for Advanced Glycation End Products; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Chromatography, Affinity; Cromolyn Sodium; Deoxycytidine; Drug Synergism; Flow Cytometry; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, Reporter; Immunoprecipitation; Luciferases; Mice; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Proteins | 2006 |
Mast cells and pancreatic cancer.
Topics: Animals; Cell Transformation, Neoplastic; Chemokine CCL2; Cromolyn Sodium; Mast Cells; Mice; Neovascularization, Pathologic; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc | 2008 |